Takeda Pharmaceutical (TAK) Change in Acquisitions & Divestments (2018 - 2026)

Takeda Pharmaceutical's Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at -$53.2 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 70.79% year-over-year to -$53.2 million in Q1 2026; TTM through Mar 2026 was -$15.7 million, a 200.39% decrease from a year earlier, with the FY2026 full-year figure at -$18.4 million, down 152.76% from the prior year.
• Change in Acquisitions & Divestments retreated to -$53.2 million in Q1 2026 per TAK's latest filing, from $10.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $119.3 million in Q3 2024 and bottomed at -$201.3 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $7.8 million (2025), against an average of -$16.2 million.
• Across the five-year window, Change in Acquisitions & Divestments jumped 19481.58% in 2024 and plunged 430.11% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $15.2 million in 2022, then plunged by 79.67% to $3.1 million in 2023, then soared by 656.39% to $23.4 million in 2024, then slumped by 56.75% to $10.1 million in 2025, then slumped by 624.95% to -$53.2 million in 2026.
• Per Business Quant, the three latest TAK Change in Acquisitions & Divestments figures stand at -$53.2 million (Q1 2026), $10.1 million (Q4 2025), and $19.6 million (Q3 2025).